Successful Testing and Validation of the World’s First Full-Scale HTS Coil for Renewable Power Generation
Zenergy Power plc (AIM:ZEN.L), the specialist manufacturer and developer of commercial applications for high-temperature superconductive (‘HTS’) materials, is pleased to announce that its collaborative partner for wind and hydro power, Converteam SAS, has successfully completed testing and validation of the Group’s fi rst full-scale HTS coil for renewable power generation. The full-scale coil in question was constructed by the Group at its purpose built facilities in Rheinbach, Germany and will be used in the construction of the world‘s fi rst HTS based hydro-electric power generator that has been ordered for commercial use by E.ON Wasserkraft GmbH (‘E.ON-WK’). The HTS hydro generator will be manufactured in the United Kingdom at Converteam’s facilities based in Rugby and will deliver signifi cant improvements in electrical energy effi ciency to E.ON-WK’s commercial hydro-dam and consequently increase its overall power output by 36%. As Germany‘s largest producer of hydro-electric power, E.ON-WK currently produces more than 10 billion kilowatt hours of hydro-electric power per annum. Read more ...

Key FCL Milestone: Successful testing and Launch of Commercial Grid Stability Device
Zenergy Power plc (AIM:ZEN.L), the specialist manufacturer and developer of commercial products utilising high-temperature superconductive (‘HTS’) materials, is pleased to announce that it has successfully completed testing of the Group‘s fi rst commercial HTS Fault Current Limiter (‚FCL‘) in order to qualify it for installation into commercial electricity power grids. The FCL unit in question is based upon a prior development model that was designed, built and tested by the Group last year and has been constructed for installation into the commercial electricity grid of Southern California Edison (‚SCE‘). The Group will now deliver the completed FCL unit to SCE in December of this year, after which it will be installed into the Avanti distribution circuit of the Californian power grid following SCE’s own pre-installation tests. Installation of the unit into the grid is expected to occur in the fi rst quarter of next year.Read more ...

MDdatacor and BlueCross BlueShield of North Dakota Announce Contract to Help Build the Country’s First State-Wide Patient-Centered Medical Home Initiative
Atlanta, GA, October 14, 2008 – MDdatacor, Inc., a leader in health care quality management solutions for health plans and providers, and Blue Cross Blue Shield of North Dakota (BCBSND), North Dakota's largest provider of health care coverage, today announced the MediQHome program, the country’s first state-wide patient-centered medical home initiative.

A patient-centered medical home model provides patient care through a personal physician trained to provide continuous and comprehensive care. The hallmarks of the patient-centered medical home model include improved quality, safety, and more coordinated care. BCBSND, which serves more than 475,000 members, seeks to serve as an industry leader in implementing this care delivery model. Read more ...

Zenergy HTS Induction Heater Operations Update
Zenergy Power plc (AIM: ZEN.L), the specialist manufacturer and developer of commercial applications for high-temperature superconductive (‘HTS‘) materials, is pleased to provide the following update on the industrial performance of the world‘s fi rst HTS induction heater installed into the commercial premises of Weseralu GmbH (‘Weseralu’) in July of this year.

Following its installation by the Group and its manufacturing partner, Bültmann GmbH, the machine is now fully integrated into Weseralu’s commercial operations, where, for over three months, it has operated consistently and at full capacity. Operational data results collected by Weseralu have demonstrated that throughout this period, the induction heater has delivered signifi cant increases in industrial output whilst greatly improving the overall energy effi ciency of Weseralu’s industrial operation. Furthermore, the Group is delighted to report that the machine’s performance data has comfortably surpassed any previous expectations of both the customer’s and Zenergy’s management teams. Read more ...

MDdatacor Chosen to Support Health Care Quality Program for Blue Cross and Blue Shield of Nebraska
Atlanta, GA, September 22, 2008 – MDdatacor, Inc., a leader in health care quality management solutions for health plans and providers, today announced a new contract with Blue Cross and Blue Shield of Nebraska (BCBSNE) to support the health plan’s quality program, which initially focuses on members with diabetes and hypertension. BCBSNE serves nearly 700,000 members throughout the state.

BCBSNE will rely on MDdatacor’s patented and interoperable CareInformatixTM technology to automate the collection of clinical data from primary care physician practices’ existing electronic medical record, practice management, lab and registry systems, as well as transcribed notes, which means that even physicians without electronic systems will be able to participate in the program. MDdatacor is currently the only company able to aggregate clinical data directly from physicians’ own patient records, resulting in access to the most comprehensive patient data. Read more ...

ROXRO PHARMA Presents Migraine Proof-of-Concept Data at the European Headache and Migraine Trust International Congress 2008
MENLO PARK, CA (September 06, 2008) ROXRO PHARMA, Inc. today presented additional results of its product candidate ROX-828 which is in development for the treatment of migraine pain. These data are a follow on to its previously announced successful Phase 2 proof of concept study. The data were presented in a poster at The European Headache and Migraine Trust International Congress in London. ROXRO presented additional information on ROX-828 indicating that more patients treated with ROX-828 achieved pain relief and pain free status than those treated with placebo. ROXRO also presented data indicating that associated migraine symptoms, such as nausea, vomiting and sensitivity to noise were improved with ROX-828 treatment. In addition, more patients who received ROX-828 reported much better and very much better efficacy 2 hours after dosing, than did patients who received placebo (p=0.008).Read more ...

Zenergy Announces Successful Operation of World’s First Commercial Full Scale HTS Induction Heater
Zenergy Power plc (AIM:ZEN.L), the specialist manufacturer and developer of commercial applications for high-temperature superconductive (‘HTS’) materials, is pleased to announce that it has completed the successful installation and operation of the world’s fi rst commercial full scale HTS induction heater for Weseralu GmbH & Co. KG (‘Weseralu’) at its manufacturing facility in Minden, Germany.

The HTS induction heater is based on Zenergy’s proprietary technology and is specifi cally designed for heating large aluminium billets that can be manipulated when softened and shaped for innumerable products in the automotive, aerospace and machine building industries. Weseralu, which currently produces 14,000 tonnes of extruded aluminium per annum, using two conventional induction heaters, ordered the unit in late September 2007, a mere four months after the completion of its development and industrial testing, as previously announced on 22 May 2007. Read more ...

Agamatrix: New WaveSense Presto™ and Pro™ Glucose Meters to Simplify Testing
Salem, New Hampshire, June 6, 2008 – The makers of the WaveSense™ line of blood glucose monitoring products (AgaMatrix, Inc.) announce the launch of the WaveSense Presto and WaveSense KeyNote Pro Blood Glucose Monitoring Systems (BGMS). The Presto is a no code meter with premium features that consumers can buy at a value price. The Pro is designed for use in institutional settings with added features for increased safety.

The Presto has all the market-leading features of AgaMatrix’s first product, the WaveSense KeyNote®, but does not require coding and is priced considerably less than no code products from the major brands. The system also has improved ergonomics and a brighter backlit display. Like the KeyNote, it requires a small sample size (0.5µl), is As Fast As 1-2-3®, and has alternate site testing. Presto builds on the existing base of WaveSense customers that is expected to exceed 1,000,000 by this fall. Read more ...

Ex-Menarini Executive to Lead UK for WaveSense
Oxford, United Kingdom, June 5, 2008 - WaveSense Europe announced today that Mr. Alec Winton, formely of Menarini Diagnostics, has joined WaveSense Europe as General Manager, UK, and that WaveSense Europe headquarters will be based in Oxfordshire. Read more ...

Block Shield announces it has conditionally agreed to acquire the entire issued share capital of Mu-Gahat Holdings Inc
Block Shield Corporation plc, the provider of innovative electronic components and processes utilised in electromagnetic compatibility (`EMC') and Radio Frequency Identification (`RFID') applications, is pleased to announce it has conditionally agreed to acquire the entire issued share capital of Mu-Gahat Holdings Inc ("Mu-Gahat"), a developer and producer of custom RFID and gaming technology solutions, for a total consideration of 29,605,263 ordinary shares at the Placing Price (the "Consideration Shares") in Block Shield (the "Acquisition"), which represents 39 per cent. of the issued share capital of the Company as enlarged by the Consideration Shares and the Placing Shares (the "Enlarged Share Capital"). Read more ...

Block Shield announces it has conditionally agreed to acquire the entire issued share capital of Mu-Gahat Holdings Inc
MENLO PARK, CA (May 05, 2008) ROXRO PHARMA, Inc. today announced it has received an Excellence and Innovation Award for the Phase 3 data of the company‘s novel intranasal pain reliever ROX-888, which is in development for the treatment of moderate-to-severe pain. Read more ...

Former WellPoint Senior Executive Appointed MDdatacor Executive Chairman; John S. Watts, Jr. to Lead Board of MDdatacor, Inc.
Atlanta, GA, April 29, 2008 – MDdatacor, Inc., a leader in healthcare quality management solutions or health plans and providers, today announced it has appointed John S. Watts Jr., former president and CEO of WellPoint Inc.'s Commercial and Consumer Business, as executive chairman of its Board of Directors.

Watts has more than 25 years of experience in building, growing and leading large health plan organizations. He spent 12 years at WellPoint, the nation's largest insurer with approximately 35 million members, where he held numerous executive positions, including chief executive and president of Blue Cross Blue Shield of Georgia and president and CEO of National Accounts. In his most recent position as president and CEO of WellPoint's Commercial and Consumer Business, Watts directed a $50 billion division that encompassed 14 Blue Cross Blue Shield plans. Read more ...

ROXRO Pharma Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
MENLO PARK, CA (April 28, 2008) – ROXRO PHARMA, Inc. today announced positive top-line data from a clinical study of the company's novel investigational intranasal pain reliever in the treatment of migraine and related symptoms.

The placebo-controlled proof of concept study evaluated the efficacy and safety of ROX-828, an intranasal formulation of the non-steroidal anti-inflammatory (NSAID) pain reliever ketorolac. Conducted at 17 sites in Germany and Finland, the trial involved 68 patients who received ROX-828 and 72 patients who received placebo. The study was conducted on an out-patient basis, with participants instructed to self-administer one dose of study drug when they experienced a migraine attack. Read more ...

Zenergy‘s High Temperature Superconductor (`HTS‘) Induction Heater Wins Prestigious Hermes Award
Zenergy Power plc (AIM:ZEN.L), the specialist manufacturer and developer of commercial applications for high-temperature superconductor (`HTS‘) materials, is delighted to announce it is the proud recipient of the coveted Hermes Award. Regarded as one of the most prestigious annual technology prizes, the Hermes Award was presented to Zenergy at the opening of the 2008 Hannover Fair for its groundbreaking HTS induction heater; the first industrial application of its kind to employ superconductor technology to a widely used industrial process.

The Award was presented to Zenergy, in conjunction with its collaborative manufacturer Bültmann GmbH, at the opening ceremony of the Hannover Fair on 20th April 2008 in the presence of distinguished guests notably including the German Chancellor Dr. Angela Merkel. The Hannover Fair was first established in 1947 and is the world‘s largest annual industrial technology exhibition, incorporating 10 flagship international tradeshows and over 6,400 exhibitors, which in turn attracts in excess of 240,000 visitors. In addition to the honour of being only the fifth company to receive the Hermes Award, Zenergy is the beneficiary of what is acknowledged as the most generous international industrial prize of Euro100,000. The Award is presented to the most exceptional new technical product that demonstrates substantial commercial benefit and has either undergone rigorous industrial trials or reached the industrial application stage. Read more ...

Zenergy Announces Commercial Contract for Department of Homeland Security Project
Zenergy Power plc (AIM:ZEN.L), the specialist manufacturer and developer of commercial applications for high-temperature superconductive (‘HTS’) materials, is pleased to announce that it has been contracted, on fully commercial terms, to carry out a technology employment study of its patented HTS Fault Current Limiter (‘FCL’) for Consolidated Edison, Inc. (‘Con Edison’), the United States’ largest investor-owned energy company. The study will form the basis of the formal provision of technical analysis on how the Group’s FCL would protect New York City from the damaging effects of power surges, once installed into Con Edison’s power grid there. Con Edison will also use the study to evaluate the role that Zenergy’s proprietary technology can play in the creation of ‘Secure Super Grids’ in the United States. The technical analysis is a commercial contract and forms part of the US$39million U.S. Department of Homeland Security project named Hydra, which is aimed at developing power grids in the United States that can keep centres of commerce on line under all conditions – including grid events related to severe weather, accidents or terrorist attacks. Read more ...